SciVision Biotech Inc.'s product, one-injection type hyaluronic acid synovial fluid supplement"HYAJOINT Plus" has obtained medical device license. Cause of occurrence: One-injection type hyaluronic acid synovial fluid supplement ?HYAJOINT Plus?, developed and produced by the company, has obtained the Philippines medical device license. (CMDR-2024-02745).

This product contains cross-linked hyaluronic acid, which can increase joint lubrication and reduce joint friction. For patients with osteoarthritis, it can promote cartilage regeneration, relieve pain and discomfort, enhance daily mobility, and increase joint range of motion.